Clinical Trial Update: Study in ALS With Abatacept & IL-2 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating abatacept in combination with interleukin-2 in amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Abatacept (abatacept)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: COMPLETED